Americans need assurance of the availability of approved drugs and medical devices in the marketplace so that healthcare providers have more reliable inventory, experience fewer shortages, and more choices when shortages arise. Reciprocity of regulatory decisions would help to achieve that.
drug shortages
Recently, Newsday's David Olson wrote about opioids in an honest way not often seen in mainstream media. He emphasized the harm caused by the “overcorrection of the pendulum” – the shortage of medically legitimate opioids caused by ill-advised restrictions on prescribing. He gives personal accounts of practitioners, pharmacists, and patients struggling to navigate the unforgiving terrain of new laws and policies. Thumbs up to Mr. Olson for this important article.
Drug shortages mean that many patients are getting the second or third choice of a medicine, increasing the likelihood that the drug will be ineffective or only suboptimally effective, or have unwanted side effects. Reciprocity of approvals between the U.S. and certain other countries could help to address that.
Shortages of widely prescribed drugs are endemic in the U.S. To address the problem, we need a policy change that would enable overseas manufacturers to sell products in the U.S. that already have received marketing approval from certain foreign governments with standards comparable to ours and vice versa. In other words, there should be reciprocity of drug approvals.
Toilet paper always flies off the shelves when there's a crisis, whether it's real or perceived. But after nine months of COVID, there's a new "panic item": antacids. Here's why.
Can someone please explain the logic here? Does this make any sense at all?
Yesterday, ACSH friend, Dr. David Seres, the head of nutritional medicine at New York Presbyterian Hospital, and three colleagues wrote a piece for the health blog in The Hill that would drive one crazy.
ACSH advisor, Dr. Robert Glatter, an emergency room attending physician at New York s Lenox Hill Hospital, has seen more than enough when it comes to the recent plague of
ACSH advisor, Dr. Robert Glatter, an emergency room physician at New York s Lenox Hill Hospital, has seen more than enough. And they recently announced shortage of
When you re brought into an emergency room following an auto accident and there isn t enough IV saline to go around, you re not going to care all that much why. And if you re not in too much pain (because they may be out of morphine too), perhaps you ll ponder why we should even have to worry about these things.
We are reaching the height of flu season, and the percentage of healthcare workers who have gotten the flu vaccination remains unacceptably low. The goal of public health authorities is to
The shortage of generic injectable drugs in the U.S. has been an ongoing, grave (and sometimes life-threatening) problem. Although there are multiple factors given for these inexcusable shortages, the main reason is rarely mentioned: